Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.914 SEK | -7.31% | +5.75% | +8.01% |
Sales 2021 | 844K 78.11K | Sales 2022 | 1.14M 106K | Capitalization | 595M 55.09M |
---|---|---|---|---|---|
Net income 2021 | -156M -14.44M | Net income 2022 | -168M -15.55M | EV / Sales 2021 | 1,710 x |
Net cash position 2021 | 254M 23.52M | Net cash position 2022 | 68.47M 6.34M | EV / Sales 2022 | 460 x |
P/E ratio 2021 |
-10.9
x | P/E ratio 2022 |
-3.54
x | Employees | 11 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.34% |
Latest transcript on Immunovia AB
1 day | -7.31% | ||
1 week | +5.75% | ||
Current month | +39.91% | ||
1 month | +43.91% | ||
6 months | +216.89% | ||
Current year | +8.01% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 22-03-31 | |
Karl Stone
COO | Chief Operating Officer | 61 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 16-12-08 | |
Peter Andersen
CHM | Chairman | 67 | 19-12-31 |
Michael Löfman
BRD | Director/Board Member | - | 23-05-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 1.914 | -7.31% | 1,067,817 |
24-04-22 | 2.065 | +17.73% | 3,201,853 |
24-04-19 | 1.754 | -1.90% | 233,227 |
24-04-18 | 1.788 | +1.94% | 109,354 |
24-04-17 | 1.754 | -6.20% | 158,116 |
Delayed Quote Nasdaq Stockholm, April 23, 2024 at 11:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+8.01% | 8.57M | |
-45.18% | 2.61B | |
+15.62% | 1.76B | |
-2.14% | 1.51B | |
+21.84% | 1.17B | |
-13.27% | 943M | |
-21.67% | 883M | |
-6.04% | 701M | |
-15.76% | 693M | |
+12.74% | 509M |
- Stock Market
- Equities
- IMMNOV Stock